SlideShare a Scribd company logo
1 of 6
Study of Left Ventricular
Hypertrophy in patients with
Chronic Kidney Disease on
Maintainance Hemodialysis In
A Tertiary Care Setting
By Dr.Sharath Nallaperumal
1st Year Post-Graduate
General Medicine
Introduction
 Left Ventricular Hypertrophy (LVH) is the most frequent cardiac alteration in
patients with Chronic Kidney Disease (CKD) undergoing hemodialysis.
 In patients with CKD, LVH is a major independent risk factor for
cardiovascular morbidity and mortality
 LVH results in-
- Impaired LV compliance
- Increased risk for arrythmias
- Sudden cardiac arrest
 Hence, it is vital to diagnose it early in order to implement strategies to
reduce mortality
Aim
 To study LVH in patients with CKD on maintainance hemodialysis in a teriary
care setting
Objective
To assess the prevalence of Left Ventricular Hypertrophy in patients with Chronic
Kidney Disease on maintainance hemodialysis in a tertiary care setting
Methodology
 Study Design- A cross-sectional study of patients diagnosed with CKD who are on
maintainance hemodialysis in a tertiary care setting. Patients diagnosed with CKD
stage 5 who are on hemodialysis and who fit the inclusion criteria will be enrolled
in the study after getting their informed consent. Patient’s ECG and 2D
Echocardiogram done will be accessed to assess for findings of LVH. If not done or
if reports are not available, ECG and 2D Echocardiogram will be done afresh.
 Study setting- Dialysis Unit, OPD and ICU patients of General medicine and
Nephrology department of Sree Balaji Medical College and Hospital, Chromepet
 Study duration- 18 months (May 2023 to November 2024)
 Sample Size- 116 (Minimum)
Inclusion Criteria
• Adult male and female patients (aged>/=18years) diagnosed with CKD Stage 5
[eGFR<15 ml/min/1.73 m2] who are on maintainance hemodialysis
Exclusion Criteria
• Patients with CKD below the age of 18 years
• Patients with CKD Stages 1-4 who are not on hemodialysis
• Patients who undergo emergency hemodialysis (Newly diagnosed CKD)
Study Tools
 Patient’s ECG and 2D Echo reports - if not done, to be done afresh
 Patient’s RFT and other laboratory reports (if relevant)
 MS Office- Excel worksheet to analyse data set

More Related Content

Similar to SHARATH.N- THESIS PPT.pptx

Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
ahvc0858
 
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
moneralwsaby
 
Reduce the hospitalization
Reduce the hospitalizationReduce the hospitalization
Reduce the hospitalization
Anna Wu
 

Similar to SHARATH.N- THESIS PPT.pptx (20)

Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1
 
Dr.Bhargav kiran general medicine Final Dissertation topic
Dr.Bhargav kiran general medicine  Final Dissertation topicDr.Bhargav kiran general medicine  Final Dissertation topic
Dr.Bhargav kiran general medicine Final Dissertation topic
 
cardiac evaluation in kidney and liver disease
cardiac evaluation in kidney and liver diseasecardiac evaluation in kidney and liver disease
cardiac evaluation in kidney and liver disease
 
Hypertension and Anesthesia
Hypertension and AnesthesiaHypertension and Anesthesia
Hypertension and Anesthesia
 
Mixed results for heart failure therapies, journel club
Mixed results for heart failure therapies, journel clubMixed results for heart failure therapies, journel club
Mixed results for heart failure therapies, journel club
 
ACC 2024 Snippets. Dr Spandana, Cardiology pdf
ACC 2024 Snippets. Dr Spandana, Cardiology pdfACC 2024 Snippets. Dr Spandana, Cardiology pdf
ACC 2024 Snippets. Dr Spandana, Cardiology pdf
 
Diploma thesis 2018 raheli peled
Diploma thesis 2018 raheli peledDiploma thesis 2018 raheli peled
Diploma thesis 2018 raheli peled
 
ESRD pericarditis / Uremic Pericarditis
ESRD pericarditis / Uremic Pericarditis ESRD pericarditis / Uremic Pericarditis
ESRD pericarditis / Uremic Pericarditis
 
Clinical guidelines for kidney transplantation 0
Clinical guidelines for kidney  transplantation 0Clinical guidelines for kidney  transplantation 0
Clinical guidelines for kidney transplantation 0
 
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
 
Primary pulmonary hypertension
Primary pulmonary hypertensionPrimary pulmonary hypertension
Primary pulmonary hypertension
 
What's New in Congenital Heart Disease PAH?
What's New in Congenital Heart Disease PAH?What's New in Congenital Heart Disease PAH?
What's New in Congenital Heart Disease PAH?
 
ANESTHESIA PREOPERATIVE EVALUATION.pptx
ANESTHESIA PREOPERATIVE EVALUATION.pptxANESTHESIA PREOPERATIVE EVALUATION.pptx
ANESTHESIA PREOPERATIVE EVALUATION.pptx
 
International Journal of Nephrology & Therapeutics
International Journal of Nephrology & TherapeuticsInternational Journal of Nephrology & Therapeutics
International Journal of Nephrology & Therapeutics
 
Journal club 1 jan 2020
Journal club 1 jan 2020Journal club 1 jan 2020
Journal club 1 jan 2020
 
Heart Failure Grand Rounds July 2023.pptx
Heart Failure Grand Rounds July 2023.pptxHeart Failure Grand Rounds July 2023.pptx
Heart Failure Grand Rounds July 2023.pptx
 
Anticoagulation in CKD patients with AF
Anticoagulation in CKD patients with AFAnticoagulation in CKD patients with AF
Anticoagulation in CKD patients with AF
 
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
 
[Paper Report] Coronary Artery Bypass Graft versus Percutaneous Coronary In...
[Paper Report] Coronary Artery Bypass Graft versus Percutaneous Coronary In...[Paper Report] Coronary Artery Bypass Graft versus Percutaneous Coronary In...
[Paper Report] Coronary Artery Bypass Graft versus Percutaneous Coronary In...
 
Reduce the hospitalization
Reduce the hospitalizationReduce the hospitalization
Reduce the hospitalization
 

More from SriAnnaiPharmaceutic (7)

PTB DRABINAYA.pptx
PTB DRABINAYA.pptxPTB DRABINAYA.pptx
PTB DRABINAYA.pptx
 
Recognition and management of advanced liver disease.pptx
Recognition and management of advanced liver disease.pptxRecognition and management of advanced liver disease.pptx
Recognition and management of advanced liver disease.pptx
 
IMAGE OF THE WEEK...pptx
IMAGE OF THE WEEK...pptxIMAGE OF THE WEEK...pptx
IMAGE OF THE WEEK...pptx
 
PRESENTATION - KASTHURI.pptx
PRESENTATION - KASTHURI.pptxPRESENTATION - KASTHURI.pptx
PRESENTATION - KASTHURI.pptx
 
PRESENTATION - KASTHURI1.pptx
PRESENTATION - KASTHURI1.pptxPRESENTATION - KASTHURI1.pptx
PRESENTATION - KASTHURI1.pptx
 
aseptic bactiuria prevalence
aseptic bactiuria prevalenceaseptic bactiuria prevalence
aseptic bactiuria prevalence
 
Serum FERRITIN.pptx
Serum FERRITIN.pptxSerum FERRITIN.pptx
Serum FERRITIN.pptx
 

Recently uploaded

Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 

Recently uploaded (20)

How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 

SHARATH.N- THESIS PPT.pptx

  • 1. Study of Left Ventricular Hypertrophy in patients with Chronic Kidney Disease on Maintainance Hemodialysis In A Tertiary Care Setting By Dr.Sharath Nallaperumal 1st Year Post-Graduate General Medicine
  • 2. Introduction  Left Ventricular Hypertrophy (LVH) is the most frequent cardiac alteration in patients with Chronic Kidney Disease (CKD) undergoing hemodialysis.  In patients with CKD, LVH is a major independent risk factor for cardiovascular morbidity and mortality  LVH results in- - Impaired LV compliance - Increased risk for arrythmias - Sudden cardiac arrest  Hence, it is vital to diagnose it early in order to implement strategies to reduce mortality
  • 3. Aim  To study LVH in patients with CKD on maintainance hemodialysis in a teriary care setting Objective To assess the prevalence of Left Ventricular Hypertrophy in patients with Chronic Kidney Disease on maintainance hemodialysis in a tertiary care setting
  • 4. Methodology  Study Design- A cross-sectional study of patients diagnosed with CKD who are on maintainance hemodialysis in a tertiary care setting. Patients diagnosed with CKD stage 5 who are on hemodialysis and who fit the inclusion criteria will be enrolled in the study after getting their informed consent. Patient’s ECG and 2D Echocardiogram done will be accessed to assess for findings of LVH. If not done or if reports are not available, ECG and 2D Echocardiogram will be done afresh.  Study setting- Dialysis Unit, OPD and ICU patients of General medicine and Nephrology department of Sree Balaji Medical College and Hospital, Chromepet  Study duration- 18 months (May 2023 to November 2024)  Sample Size- 116 (Minimum)
  • 5. Inclusion Criteria • Adult male and female patients (aged>/=18years) diagnosed with CKD Stage 5 [eGFR<15 ml/min/1.73 m2] who are on maintainance hemodialysis Exclusion Criteria • Patients with CKD below the age of 18 years • Patients with CKD Stages 1-4 who are not on hemodialysis • Patients who undergo emergency hemodialysis (Newly diagnosed CKD)
  • 6. Study Tools  Patient’s ECG and 2D Echo reports - if not done, to be done afresh  Patient’s RFT and other laboratory reports (if relevant)  MS Office- Excel worksheet to analyse data set